ADA Scientific Sessions 2026 Abstract·6 JunCardiorenal Protective Effects of a CRFR2-Selective UCN2 Analog, HM17321, in Spontaneously Hypertensive Rats (SHR)Experiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·6 JunBody Composition and Functional Outcomes of HM17321, a CRFR2-Selective UCN2 Analog, Alone and in Combination with Myostatin/Activin Inhibition in DIO MiceExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunA Novel CRFR2 Selective UCN2 Analog, HM17321, Facilitates Weight Loss and Improves Body Composition across Animal Models of ObesityExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunRobust Antiobesity Effect and Mechanistic Insights of HM15275, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in Animal Model of ObesityExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunMetabolic Adaptation of Liver with Treatment of HM15275, a Long-Acting GLP-1/GIP/Glucagon Triple Agonist, Supporting Lean Mass PreservationExperiments in animalsInterventionsPaper